<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00954980</url>
  </required_header>
  <id_info>
    <org_study_id>14632</org_study_id>
    <secondary_id>20091634</secondary_id>
    <nct_id>NCT00954980</nct_id>
  </id_info>
  <brief_title>Evaluation of Endovenous Sclerotherapy for Treatment of Varicose Veins</brief_title>
  <official_title>Evaluation of Clinical Characteristics of Endovenous Sclerotherapy of Varicose Veins</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Oklahoma</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Oklahoma</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The overall objective will be to evaluate clinical predictors of outcomes in patients who
      undergo endovenous sclerotherapy for the treatment of varicose veins.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A prospective cohort study of patients who undergo endovenous sclerotherapy over 2 years.
      There are no deviations in usual clinical assessment and care of patients seeking varicose
      vein treatment. The purpose of this protocol is only to collect clinical and biomarker
      information related to this standard treatment.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2009</start_date>
  <completion_date type="Actual">July 2016</completion_date>
  <primary_completion_date type="Actual">December 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Frequency of obliteratin (total or partial) of injected varicosity.</measure>
    <time_frame>assessment will be at 1, 12, and 26 weeks.</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Improvement in venous stasis symptoms.</measure>
    <time_frame>assessment will be at 1, 12, and 26 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in quality of life.</measure>
    <time_frame>assessment will be at 1, 12, and 26 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Associations between clinical outcomes and biomarkers.</measure>
    <time_frame>assessment will be at 1, 12, and 26 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Recurrence of varicosities.</measure>
    <time_frame>assessment will be at 1, 12, and 26 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse events reported following procedure.</measure>
    <time_frame>assessment will be at 1, 12, and 26 weeks</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">100</enrollment>
  <condition>Varicose Veins</condition>
  <arm_group>
    <arm_group_label>Endovenous Sclerotherapy</arm_group_label>
    <description>For those who have been diagnosed with varicose veins of the leg and have been scheduled to undergo an endovenous sclerotherapy procedure</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      blood samples will be obtained for measurement of D-dimer, fibrin monomer, and total
      microparticles.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Vascular or primary care clinic patients who have been scheduled to undergo an endovenous
        sclerotherapy procedure
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinical diagnosis of varicose veins

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Suman W. Rathbun, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Oklahoma University Health Sciences Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Oklahoma Health Sciences Center campus at the OU Vascular Center</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 5, 2009</study_first_submitted>
  <study_first_submitted_qc>August 6, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 7, 2009</study_first_posted>
  <last_update_submitted>November 2, 2016</last_update_submitted>
  <last_update_submitted_qc>November 2, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 3, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Oklahoma</investigator_affiliation>
    <investigator_full_name>Suman Rathbun</investigator_full_name>
    <investigator_title>Professor of Medicine</investigator_title>
  </responsible_party>
  <keyword>Varicose Veins</keyword>
  <keyword>Superficial Thrombophlebitis</keyword>
  <keyword>Deep Vein Thrombosis</keyword>
  <keyword>Ulceration</keyword>
  <keyword>leg pain</keyword>
  <keyword>leg swelling</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Varicose Veins</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

